Solomon A, Burton M, Gower E, Harding-Esch E, Oldenburg C, Taylor H
Nat Rev Dis Primers. 2022; 8(1):32.
PMID: 35618795
DOI: 10.1038/s41572-022-00359-5.
Murthy A, Li W, Ramsey K
Curr Top Microbiol Immunol. 2016; 412:183-215.
PMID: 27370346
PMC: 6086136.
DOI: 10.1007/82_2016_18.
Kari L, Southern T, Downey C, Watkins H, Randall L, Taylor L
Infect Immun. 2014; 82(7):2756-62.
PMID: 24733093
PMC: 4097629.
DOI: 10.1128/IAI.01686-14.
Dean D, Rothschild J, Ruettger A, Kandel R, Sachse K
Emerg Infect Dis. 2013; 19(12):1948-55.
PMID: 24274654
PMC: 3840858.
DOI: 10.3201/eid1912.130656.
Hu V, Holland M, Burton M
PLoS Negl Trop Dis. 2013; 7(2):e2020.
PMID: 23457650
PMC: 3573101.
DOI: 10.1371/journal.pntd.0002020.
A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.
Kari L, Whitmire W, Olivares-Zavaleta N, Goheen M, Taylor L, Carlson J
J Exp Med. 2011; 208(11):2217-23.
PMID: 21987657
PMC: 3201208.
DOI: 10.1084/jem.20111266.
Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.
Kari L, Whitmire W, Crane D, Reveneau N, Carlson J, Goheen M
J Immunol. 2009; 182(12):8063-70.
PMID: 19494332
PMC: 2692073.
DOI: 10.4049/jimmunol.0804375.
Macaque models of human infectious disease.
Gardner M, Luciw P
ILAR J. 2008; 49(2):220-55.
PMID: 18323583
PMC: 7108592.
DOI: 10.1093/ilar.49.2.220.
Reactivation of chlamydial genital tract infection in mice.
Cotter T, Miranpuri G, Ramsey K, Poulsen C, Byrne G
Infect Immun. 1997; 65(6):2067-73.
PMID: 9169733
PMC: 175285.
DOI: 10.1128/iai.65.6.2067-2073.1997.
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide.
Igietseme J
Immunology. 1996; 87(1):1-8.
PMID: 8666420
PMC: 1383960.
An in vitro model for immune control of chlamydial growth in polarized epithelial cells.
Igietseme J, Wyrick P, Goyeau D, Rank R
Infect Immun. 1994; 62(8):3528-35.
PMID: 8039923
PMC: 302987.
DOI: 10.1128/iai.62.8.3528-3535.1994.
A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.
Murdin A, Su H, Manning D, Klein M, Parnell M, Caldwell H
Infect Immun. 1993; 61(10):4406-14.
PMID: 7691749
PMC: 281173.
DOI: 10.1128/iai.61.10.4406-4414.1993.
Effect of bacterial secondary infection in an animal model of trachoma.
Taylor H, Kolarczyk R, Johnson S, Schachter J, PRENDERGAST R
Infect Immun. 1984; 44(3):614-6.
PMID: 6609886
PMC: 263644.
DOI: 10.1128/iai.44.3.614-616.1984.
Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting.
Caldwell H, Stewart S, Johnson S, Taylor H
Infect Immun. 1987; 55(1):93-8.
PMID: 3539809
PMC: 260284.
DOI: 10.1128/iai.55.1.93-98.1987.
Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.
Morrison R, Lyng K, Caldwell H
J Exp Med. 1989; 169(3):663-75.
PMID: 2926323
PMC: 2189293.
DOI: 10.1084/jem.169.3.663.
Experimental chlamydial keratitis in rabbits. Correlation with chlamydia infected McCoy tissue culture cells.
Abu El-Asrar A, Maudgal P, EMARAH M, Missotten L
Doc Ophthalmol. 1988; 69(4):353-69.
PMID: 2849533
DOI: 10.1007/BF00162749.
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.
Williams D, Bonewald L, Roodman G, Byrne G, Magee D, Schachter J
Infect Immun. 1989; 57(5):1351-5.
PMID: 2707849
PMC: 313281.
DOI: 10.1128/iai.57.5.1351-1355.1989.
Chlamydia trachomatis infections in infants.
Numazaki K, Wainberg M, McDonald J
CMAJ. 1989; 140(6):615-22.
PMID: 2645987
PMC: 1268751.
Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.
Whittum-Hudson J, Taylor H
Infect Immun. 1989; 57(10):2977-83.
PMID: 2476396
PMC: 260758.
DOI: 10.1128/iai.57.10.2977-2983.1989.
Conjunctival lymphocyte subsets in trachoma.
Burd E, Tabbara K, Nasr A, Taylor P
Int Ophthalmol. 1988; 12(1):53-7.
PMID: 2464551
DOI: 10.1007/BF00133782.